Michael Geldart

Michael Geldart has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Biotelemetry, Inc. and Cardionet Inc. We count 5 filings; the first trade dates from 11 June 2012 and the latest from 17 June 2015.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 19 June 2015 came the latest disclosure, a share grant for €52k in Biotelemetry, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.